284 related articles for article (PubMed ID: 27208161)
21. Histone deacetylase 7: a signalling hub controlling development, inflammation, metabolism and disease.
Wang Y; Abrol R; Mak JYW; Das Gupta K; Ramnath D; Karunakaran D; Fairlie DP; Sweet MJ
FEBS J; 2023 Jun; 290(11):2805-2832. PubMed ID: 35303381
[TBL] [Abstract][Full Text] [Related]
22. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases.
Lahm A; Paolini C; Pallaoro M; Nardi MC; Jones P; Neddermann P; Sambucini S; Bottomley MJ; Lo Surdo P; Carfí A; Koch U; De Francesco R; Steinkühler C; Gallinari P
Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17335-40. PubMed ID: 17956988
[TBL] [Abstract][Full Text] [Related]
23. The biology and therapeutic implications of HDACs in the heart.
McKinsey TA
Handb Exp Pharmacol; 2011; 206():57-78. PubMed ID: 21879446
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in class IIa histone deacetylases research.
Asfaha Y; Schrenk C; Alves Avelar LA; Hamacher A; Pflieger M; Kassack MU; Kurz T
Bioorg Med Chem; 2019 Nov; 27(22):115087. PubMed ID: 31561937
[TBL] [Abstract][Full Text] [Related]
25. Histone Deacetylases in Kidney Physiology and Acute Kidney Injury.
Hyndman KA
Semin Nephrol; 2020 Mar; 40(2):138-147. PubMed ID: 32303277
[TBL] [Abstract][Full Text] [Related]
26. Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes.
Lombardi PM; Cole KE; Dowling DP; Christianson DW
Curr Opin Struct Biol; 2011 Dec; 21(6):735-43. PubMed ID: 21872466
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the class IIa histone deacetylases substrate specificity.
Kutil Z; Meleshin M; Baranova P; Havlinova B; Schutkowski M; Barinka C
FASEB J; 2022 May; 36(5):e22287. PubMed ID: 35349187
[TBL] [Abstract][Full Text] [Related]
28. Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma.
Yang Q; Falahati A; Khosh A; Mohammed H; Kang W; Corachán A; Bariani MV; Boyer TG; Al-Hendy A
Cells; 2022 Nov; 11(23):. PubMed ID: 36497061
[TBL] [Abstract][Full Text] [Related]
29. The important role of histone deacetylases in modulating vascular physiology and arteriosclerosis.
Zhao TC; Wang Z; Zhao TY
Atherosclerosis; 2020 Jun; 303():36-42. PubMed ID: 32535412
[TBL] [Abstract][Full Text] [Related]
30. Role of histone deacetylases in bone development and skeletal disorders.
Wang JS; Yoon SH; Wein MN
Bone; 2021 Feb; 143():115606. PubMed ID: 32829038
[TBL] [Abstract][Full Text] [Related]
31. The roles of histone deacetylases in kidney development and disease.
Liu H
Clin Exp Nephrol; 2021 Mar; 25(3):215-223. PubMed ID: 33398599
[TBL] [Abstract][Full Text] [Related]
32. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
33. Converse role of class I and class IIa HDACs in the progression of atrial fibrillation.
Zhang D; Hu X; Li J; Hoogstra-Berends F; Zhuang Q; Esteban MA; de Groot N; Henning RH; Brundel BJJM
J Mol Cell Cardiol; 2018 Dec; 125():39-49. PubMed ID: 30321539
[TBL] [Abstract][Full Text] [Related]
34. Novel Histone Deacetylase Class IIa Selective Substrate Radiotracers for PET Imaging of Epigenetic Regulation in the Brain.
Bonomi R; Mukhopadhyay U; Shavrin A; Yeh HH; Majhi A; Dewage SW; Najjar A; Lu X; Cisneros GA; Tong WP; Alauddin MM; Liu RS; Mangner TJ; Turkman N; Gelovani JG
PLoS One; 2015; 10(8):e0133512. PubMed ID: 26244761
[TBL] [Abstract][Full Text] [Related]
35. The role of dietary histone deacetylases (HDACs) inhibitors in health and disease.
Bassett SA; Barnett MP
Nutrients; 2014 Oct; 6(10):4273-301. PubMed ID: 25322459
[TBL] [Abstract][Full Text] [Related]
36. Histone deacetylases in cardiovascular and metabolic diseases.
Bagchi RA; Weeks KL
J Mol Cell Cardiol; 2019 May; 130():151-159. PubMed ID: 30978343
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory selectivity among class I HDACs has a major impact on inflammatory gene expression in macrophages.
Cao F; Zwinderman MRH; van Merkerk R; Ettema PE; Quax WJ; Dekker FJ
Eur J Med Chem; 2019 Sep; 177():457-466. PubMed ID: 31181405
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases.
Gatla HR; Muniraj N; Thevkar P; Yavvari S; Sukhavasi S; Makena MR
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30841513
[TBL] [Abstract][Full Text] [Related]
39. Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents.
Wahi A; Jain P; Sinhari A; Jadhav HR
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):675-702. PubMed ID: 37615708
[TBL] [Abstract][Full Text] [Related]
40. Histone deacetylase (HDACs) inhibitors: Clinical applications.
Shanmukha KD; Paluvai H; Lomada SK; Gokara M; Kalangi SK
Prog Mol Biol Transl Sci; 2023; 198():119-152. PubMed ID: 37225317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]